Creation
Draft
Initial
Detailed
Accepted
Adoption
Idea Description
Supplementary Information
Innovation 'Elevator Pitch':
Our expert people and advanced health analytics reveal insights from complex data that enable health & care professionals working across the West Midlands to make better decisions for the patients and populations they serve.
Overview of Innovation:
Sollis and the world-renowned Johns Hopkins University have collaborated to produce a population health analytics platform that helps health & care professionals transform services for patients and populations.

Sollis Clarity and The Johns Hopkins ACG ®System is a person-focused case-mix system that captures the multi-dimensional nature of an individual’s health. It considers the total disease experience of each patient, including the implications of co-occurring disease, encouraging a holistic view of the patient rather than the management of specific diseases or episodes.

Sollis Clarity supports:
  • Case Finding - Patient level risk stratification
  • Resource Management - Case-mix risk adjustment and benchmarking
  • Population Health Needs Assessment - Population level risk stratification
  • Fair Shares Budgeting - Capitated budget setting

Sollis Clarity delivers robust business analytics and data management to identify and analyse populations across the continuum of care to help health & care providers and commissioners get a precise understanding of patterns of mult-morbidity across populations and its relationship to utilisation, costs and outcomes.

Sollis Clarity delivers insights into the morbidity patterns of different populations, supporting population health management, service transformation, integrated care and, ultimately, better outcomes for patients.

Sollis Clarity goes beyond patient level risk stratification. Risk stratification at a population level helps the health economy — providers and commissioners — analyse and minimise the progression of diseases and the exacerbation of co-morbidities. When combined with the ACG System it is a comprehensive family of measurement tools designed to help explain and predict how healthcare resources are delivered and consumed.

Sollis Clarity provides the evidence base to support:
  • Planning and service re-design
  • Clinical decision making
  • Outcomes-based commissioning
  • Risk stratification and predictive modelling
  • Population profiling / segmentation
  • Case-mix adjusted benchmarking
  • Integrated multi-disciplinary care
To view Sollis - Nigel's Story - click here.
To view UK Healthcare data analytics for NHS CCGs - click here.
To view The Proactive Care at Brighton & Hove - click here.
To view Population Profiling at NHS Slough CCG - click here.
To view Using Data to Gain Greater Insight - click here.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
Similar Content4
Innovation 'Elevator Pitch':
This is a risk stratification model that aims to predict and prevent crisis by segmenting the mental health patient population by risk and likelihood of an acute mental health crisis.
 
Overview of Innovation:
Currently, the response to mental health crisis is mostly reactive. To address the increasing pressures faced by the urgent care services by patients presenting with mental health crisis, prevention and early intervention must be prioritised. This will not only alleviate pressure of several emergency care services but will also improve patients’ prospect by ensuring  timely interventions that avoid patients’ mental health deteriorating further.

The Rapid, Assessment, Interface and Discharge Plus project, in partnership with Telefonica Alpha, aims to achieve this by developing and validating a risk stratification model and algorithm to predict mental health crises. The risk stratification model will use four years of pseudonymised clinical and sociodemographic data to capture potentially robust predictors from a wide range of sources to provide an overall indication of a patient’s risk of experiencing a mental health crisis.

By applying the model onto the Trust’s mental health population, we can stratify the patients into different risk groups and subsequently target the highest risk segment of the population for preventative early intervention with improved accuracy. This information will be provided to clinicians who will determine the necessary measures required to prevent the progression from high-risk status to actual mental health crisis. This will act as a ‘clinical support tool’ for clinicians in making their decision and does not replace the clinicians decision on how to manage patients.

The project will look at how the risk stratification model can be implemented into practice, working with Community Mental Health Teams (CMHTs) to pilot the model. The model will be refined, tested and validated by a team of data analysts, clinicians and to embed it into systems for routine clinical care. Using this tool can help improve patient care by avoiding unnecessary admission, presentation at A&E, or potentially prevent an escalation in the worsening of a patient’s mental health state.
 
Stage of Development:
Trial stage - Trial stage to prove that the idea actually works as intended
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption
Benefit to NHS:
In a pressurised financial environment, faced continually with greater challenges to meet quality objectives, this innovative product can simultaneously improve patient outcome by reducing intensity and/or preventing mental health crisis as well as reduce costs by stopping the over saturation of emergency services.
 
The use of technology systems and data is at the centre of the NHS Five Year Forward View. It highlights how the use of data and technology will transform outcomes for patients and citizens. The insights derived from the risk stratification model will help the NHS explore how the information/ data they hold could be used in clinical settings to benefit patients. It will highlight patterns in the data that can be used to develop proactive preventative measures to support mental health patients.  The ability to stratify risk and predict those who might be at risk of mental health supports frontline mental health clinicians to de-escalate situations before crises arise. This leads to improved patient outcomes by avoiding the further deteriorating on mental health and potential saving where the intervention has prevented an entry to the crisis care system.
 
The reduction in demand for emergency and inpatient mental health services will relieve the pressure from the crisis care pathways resulting in enhanced patient experiences, improved staff support and morale, and greater efficiency and effectiveness within urgent care mental health services to respond to current and future patient needs.
 
Initial Review Rating
1.00 (1 ratings)
Benefit to WM population:
Mental health crisis is a significant and increasing problem across Birmingham and Solihull. The number of crises in the region has increased by an average of 7% year on year for the past 5 years and is projected to increase further in the future, according to the Midlands and Lancashire CSU. Therefore, this places increased level of pressure on urgent care services and it is important to be able to introduce proactive measures to stop at risk patients from going into crisis.

The redesign of the crisis care pathway is a key NHS England target for CCGs and a central theme within the STPs. Within the Birmingham and Solihull STP, one of the key mental health objectives is to ‘Manage – preventing mental health crises and managing them better when they do’. Identification of at risk patients and supporting them by intervening sooner fall in line with the STP objective and while this tool doesn’t directly prevent the onset of crisis, it helps refine predictions and manage at risk patients proactively. The use of data-informed decision making leads to better clinical outcomes for West Midlands patients and can potentially release both capacity and resources across the emergency and urgent care system
Current and planned activity: 
The risk stratification model was developed collaboratively between BSMHFT and Telefonica Alpha as part of the Rapid, Assessment, Interface and Discharge Plus NHS Test Bed. The pilot work testing is being supported by The Health Foundation.
 
The tool is planned to be tested in real time by Community Mental Health Teams (CMHTs) in Birmingham and Solihull from September 2018. The CMHTs were identified to be in the most suitable position to be able to utilise a predictive model for crisis presentation into their working practice. The patients at risk will be flagged in real time and this will be reviewed by the CMHTs and an effective intervention put in place to avert the crisis. A robust evaluation is being conducted by the CSU looking at the effectiveness of the tool in supporting clinician’s decision making.
Return on Investment (£ Value): 
N/A
Return on Investment (Timescale): 
N/A
Ease of scalability: 
3
Read more
Hide details
Innovation 'Elevator Pitch':
Sometimes it’s hard to prove impact. Risk Tracker helps organisations providing preventative services to record their work & demonstrate success. Provided free for anyone to use (under open license) Risk Tracker is for use on desktop & mobile devices
Overview of Innovation:
Risk Tracker is a powerful tool for managing clients and demonstrating outcomes. Designed to record information without getting in the way of the service you provide, it requires collection of a minimal amount of information from clients, but provides you with the flexibility to customise.
 
One of the key challenges for organisations who provide preventative services is connecting your clients’ progress with the complex range of National Outcome Frameworks. Inside Outcomes continuously maintains the policy environment to ensure that your reports will always reflect the most recent National Outcome Frameworks and, as the Frameworks evolve, we keep you up to date with the impact this will have on your day-to-day operation.
 
We have collated a database of issues that are common to preventative services. The system has been designed to support care navigation services by providing a quick tool to record client notes, measure outcomes and store files.
 
The Inside Outcomes Risk Tracker tool helps organisations to:
  • Record the common issues that clients present to services
  • Measure changes in those issues over time
  • Demonstrate the impact organisations have had in an evidence based way
  • Measure the impact organisations have had against National Outcome Frameworks
We have created a series of custom Risk Maps that reflect the issues clients commonly report, and aligned them with the public health life course. These Risk Maps cover diverse issues such as financial planning, housing and wellbeing, because we know the complexity of individual circumstances has an impact on your ability to provide services.

Our Risk Maps cover: We are also able to tailor risk maps to reflect service specific needs such as:-  
We also provide the facility to run anonymised open data reports that highlight social need in a particular area. Because we used a standardised format for recording the issues that people present we can aggregate data across multiple agencies to create a powerful, live commissioning tool.
 
We provide Risk Tracker free for anyone to use. We provide it under an open license so that you can run it in any way you want or even adapt the code for your own uses. You can access the code repository on our Github site. You can access the Risk Tracker manual here.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Health is influenced by a range of social, environmental and economic factors which are beyond the remit of the health sector.
 
Health services, social care and housing are all focused on delivering better outcomes at lower cost to public purse and finding ways of improving the effectiveness and better understanding the value of preventative services.
 
Risk Tracker measures the impact of organisations against national outcome frameworks, supporting them to translate the things they do into the outcomes that commissioning bodies are measured against.
 
Commissioners need to identify what services are required to deliver improvements in the prevention, diagnosis and treatment of physical and mental illness in their local population, Risk Tracker provides important data to identify top priorities and opportunities for transformation.
 
It helps commissioners to identify sub groups within their population and consider service requirements across the system, creating the person-centred services patients want and need.
 
Risk Tracker is a useful tool for analysing population data and identifying those who would gain most from the services and interventions being considered, commissioners then use this information to plan, deliver and monitor services for their local population.
 
When contracting for services, commissioners are looking for positive social outcomes, which have a lasting impact with benefits for patients that can be clearly demonstrated.
 
With Risk Tracker, information is used to improve services and influence commissioning decisions. Through recording client issues in a common format Risk Tracker allows the outcomes from disparate services to be compared and contrasted. For example, the cross over in issues that the clients present to substance misuse services, mental health services and housing associations mean that data can be aggregated together.

As all data is stored in a single, secure, compartmentalised system we can create aggregated, anonymised maps of social need. The live data that can be produced records social need and is an essential tool in commissioning services against evidenced social need.
 
Investing in prevention and better health outcomes can be part of the solution to the challenges of increasing levels of need along with shrinking budgets. Effective preventative interventions can reduce health and social care costs and the need for welfare benefits. Better health can also enhance resilience, employment and social outcomes.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Risk Tracker helps commissioners to plan services which meet national standards and local ambitions, by combining knowledge of existing service performance and population needs.
 
Commissioners traditionally do not have access to live local data. Having the ability to extract accurate data on health and wellbeing needs for a particular area supports a flexible approach to commissioning against need.
 
The methodology that underpins our system encourages services to carry out a whole person assessment.  This means exploring the range of issues that might be present in an individual’s life. Through identifying a range of interdependent issues, services can integrate how they work around an individual and improve their outcomes.
 
An important component of planning for transformation is recognising where services may
need to be decommissioned. Risk Tracker can help to identify where less effective approaches to service delivery are to be found. With a good understanding of how a service is currently operating commissioners can identify potential opportunities for innovation and improvement.
 
With Risk Tracker commissioners can develop service specifications that focus on paying for services which produce improved outcomes for their patients, rather than reimbursing providers for activity.
 
Risk Tracker will provide commissioners with the information they need to develop a vision of future service provision that will improve the health & wellbeing of individuals and communities in the West Midlands.
 
We provide Risk Tracker free for anyone to use. We provide it under an open license so that you can run it in any way you want or even adapt the code for your own uses. You can access the code repository on our Github site. You can access the Risk Tracker manual here.
Current and planned activity: 
Risk Tracker is a cloud based system & is constantly going through development as services identify new functions. We are currently exploring developing risk maps to support refugees & asylum seekers, people with disabilities, carers & suicide prevention.

Our next significant software release will incorporate individual access to records & the ability for clients to move their records from one agency to another. We believe that a person-centred approach to improving health & wellbeing requires the ability for individuals to manage their own records.
 
We would like WMAHSN to help to scale up Risk Tracker across the WM region. It is provided free of charge under an open license & users can run it in any way they want, even adapt the code for their own uses. By using WMAHSN’s network to promote this opportunity, WM commissioners can develop service specifications that focus on paying for services which produce improved outcomes for patients rather than reimbursing providers for activity.
What is the intellectual property status of your innovation?:
Inside Outcomes own the full IP for the product but release it for use under an open source license. 
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Regional Scalability:
The Risk Tracker system has been built to be delpoyed at scale. The system can manage an unlimited number of organisations, and projects within organisations. The platform the system is built on is designed to dynamically utilise server capacity in line with the number of organsations using it. 
Measures:
The prinicple outcome we are aiming for is to be able to produce live data on social need for an area. 
Adoption target:
We are looking at opportunities to support neighbourhood working in line with strategic objectives of the West Midlands Combined Authority. The Risk Tracker system has been designed to set a basis for metrics in disaparate organisations and be used to integrate services using a common format of data collection. 
Read more
Hide details
Innovation 'Elevator Pitch':
ProReal was built using 3D gaming technology, this evidence-based immersive platform helps people create a visual representation of how they experience a situation so they can explore different perspectives, visualise futures & solve problems
Overview of Innovation:
ProReal’s innovative technology provides its users (clients, service users, patients) with a safe, secure & confidential visual way to describe how they experience the world. With support & facilitation users can label strong feelings & name issues, as well as articulate hopes & concerns all of which are critical for building resilience & supporting recovery.

Independent research shows that the use of the software is associated with emotional & cognitive responses, reductions in psychological distress & building of empathy & insight.

The ProReal platform helps people create a visual representation of how they experience a situation so they can explore different perspectives, visualise futures & solve problems. Clients enter a secure, virtual landscape & add avatars & props to create representations of real-world scenarios.

Clients experience increased self-awareness & rapid empathy building leading to improved relationships. Costs are reduced by enabling faster & more effective change & communication without the need to travel. Its use is associated with significant reductions in stress & self-criticism & is being used by a growing number of health & social care organisations.


ProReal features:
  • Avatars: unlimited number of avatars available
  • Symbols: a selection of symbols/props to represent various aspects of a client’s world (eg elephant, minefield, clock, mirror etc)
  • Environment & sessions: naming function provides meaning & context
  • Views & functionality: views from avatars & roaming camera provides different perspectives
ProReal benefits:
  • Faster & more effective change
  • Actionable insight
  • Reduces costs
  • Increases self-awareness, self-confidence & self-expression
  • Increases engagement
  • Associated with reductions in stress & self-criticism
  • More effective communication of vision, priorities & values
  • Rapid empathy building & improved relationships & trust
  • Convenient
  • Secure, password protected login & encrypted data

ProReal continues to work with clinicians & academics & in particular NIHR MindTech to explore the use of its software with a range of disorders & clients including adults with personality disorder, young people with anxiety, depression, trauma & eating disorders.

Our product development is underpinned by extensive & ongoing clinical & corporate research & end-user input.

This means the benefits of our software are evidence-based by independent & rigourous evaluation & meet the needs of our users. Discover more about our evidence-base here.


 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Digital health / Innovation and adoption
Benefit to NHS:
£9.49 billion was planned to be spent by CCGs on mental health services in 2016/17 – up from £9.15 billion in 2015/16. This amounts to 13.1% of planned CCG spending, up from 12.5% in 2015.16 Figures for individual CCG areas can be found using NHS England’s Mental Health Five Year Forward View Dashboard.  This does not account for all spending on mental health services, because specialised mental health commissioning is the responsibility of NHS England rather than CCGs.
 
Independent research shows that the use of the software is associated with emotional and cognitive responses, reductions in psychological distress and building of empathy and insight.
 
ProReal tailors its services to a wide range of organisations and service user needs to help them to find the right digital solution to accelerate change and improve engagement.
 
ProReal’s avatar-based therapy is a flexible and cost-effective solution. Having completed two research studies funded by SBRI Healthcare (an NHS England funded initiative to develop products that address unmet health needs) it has been proven to be effective with adults and young people. Click here for more information. As at March 2018, South London and Maudsley NHS Foundation Trust and Mersey Care NHS Foundation Trust are using/have commissioned ProReal for use with service users.
 
The software has been designed to be very easy to use - most clients learn how to use it in the first 5-10 minutes. For those using it with others in their work, most people require 15-20 hours of training, much of which is practice time. Online training is delivered via three webinars, reading material, reflective practice/assignment work and a formal assessment at the end. Face-to-face training is also offered for groups.
 
A suitable laptop or desktop computer (Windows or Mac are fine), an unrestricted internet connection and permission to install the software on your device is required. ProReal can be accessed 24/7 online via a secure login providing flexibility, convenience and increased access for clients to do self-help online.
 
ProReal provides many benefits from accelerated insight to better engagement of all which help to reduce costs.

Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
There are an estimated 4.032 million people in 2014–15 living in the West Midlands Combined Authority (WMCA). The population is culturally diverse with over 22% from Black & Asian Minority Ethnic communities, ranging from 2.3% in Cannock Chase to 42% in Birmingham.
 
Nearly a quarter of adults living in the WMCA are experiencing a mental health problem at any one time. The risks of poor mental health are not uniformly distributed across the WMCA population. They are influenced by social, economic & physical environmental factors & social inequalities in particular.
 
The aggregate economic & social cost of mental health problems in the WMCA is estimated at around £12.6 billion in 2014–15 equivalent to a cost of about £3,100 per head of population.
 
Mental ill health is estimated to cost the NHS nearly £2 billion a year in the WMCA. Only about half of this represents the direct costs of treatment & care for people with diagnosable mental health problems. The other half arises mainly because large numbers of people with long-term physical conditions such as diabetes & asthma, also suffer from depression or anxiety & this greatly increases the costs of physical health care.
 
Following the successes of the use of our software in commercial settings we had long been of the opinion that it could be beneficial in a healthcare capacity as well. To begin our investigation of this theory we secured funding from NHS England’s SBRI Healthcare programme as part of their initiative to find new technology solutions to unmet mental healthcare needs. This ‘Phase 1’ contract allowed us to conduct a pilot study using the ProReal software with a small group of adult offenders who were residents of a therapeutic wing of a category B prison in the north of England.
 
Over the course of 7 weeks our therapeutic intervention at this Serco managed prison consisted of 6, hour-long, group sessions lead by a qualified counsellor on the prison staff who we trained in the use of the ProReal software.
 
Results indicated that using our software improved participants’ capacity to elicit emotional responses & initiate further cognitive processing – both fundamental aspects of improved mental health. The study also produced good preliminary indications that using the ProReal software helps reduce psychological distress & improve general wellbeing. In addition participants reported enhanced levels of self-expression, new insights, development of empathy & the ability to build stronger relationships.
 


Current and planned activity: 
We would like to connect with the WMAHSN Mental Health Innovation Network to help to drive the adoption of ProReal across the region.
 
If you would like copies of our completed evaluation reports or to find out about our ongoing research please contact us.
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
N/A
Ease of scalability: 
2
Read more
Hide details
Innovation 'Elevator Pitch':
Dip.io, a CE approved product turns the smartphone into a clinical grade device enabling lay-users to test urine in their own home, with clinical accuracy and share results electronically with their clinician. 
Overview of Innovation:
42m urine tests a year are undertaken in the NHS to screen for a wide range of conditions. Currently patients collect a sample at home and bring it to the clinic or provide a sample in the clinic where it is either tested on site or sent to a laboratory. This is inefficient, inconvenient for the patient and presents opportunity for improvement in patient experience, clinical quality and cost efficiency.
 
Healthy.io is the first company to turn the smartphone into a regulatory-approved clinical device. Its first product, Dip.io, uses computer vision and user centric design to turn the smartphone into a urinalysis device. Built around existing semi-quantitative urinalysis dipsticks, Dip.io complements established clinical efforts by empowering patients to test themselves at home with no quality compromise, and securely share results with a clinician.
 
Healthy.io is empowering patients to take urine testing into their own hands, opening up an immense opportunity to improve preventive efforts and enable early interventions. Key pathways in which digital urinalysis has strong potential to improve patients’ lives and reduce cost to the NHS:
  • Antenatal care: women with hypertension or diabetes in pregnancy have a higher risk of developing pre-eclampsia, a leading cause of maternity morbidity. Dip.io has proven through a usability study at Johns Hopkins to improve women’s experience and could reduce outpatient appointments amongst high risk pregnant women. 
  • Chronic Kidney Disease (CKD): Home-based screening of albumin:creatinine (ACR) for people with diabetes or high blood pressure, to increase adherence to NICE CG 182 and diabetes care process beyond the current level of 50%.
  • Urinary tract infections (UTI): opportunity to improve self-management for patients at risk of admission from UTI (e.g. MS), reduce the 5m GP attendances for UTI in primary care and create digital pathways for pre-op assessment  through using digital urine testing, within existing clinical guidelines.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Benefits to NHS in line with FYFV:
  • Maternity Safety (Proteinuria screening): The Maternity Transformation Programme (Better Births) prioritises improvement in maternity safety and provision of consistent quality. This includes halving the rates of stillbirths, neonatal and maternal deaths by 2025. Around 15% of women with hypertension or diabetes in pregnancy have a higher risk of developing pre-eclampsia, a leading cause of maternity morbidity. Automated home-screening for proteinuria in at-risk pregnancies has the potential to early identify pre-eclampsia, save £1,500 for each avoided false negative, save up to £75m by reducing 60% of outpatient appointments (3rd trimester) and reduce antenatal consultation time by 25%.
 
  • Primary Care (Diabetes and CKD screening): Smartphone enabled self-testing offers a critical complement to existing population health efforts by shifting testing from primary care to the home. Providing alternatives to face-to-face contact frees up GP resources and nursing time. NICE recommends that every person at increased risk of CKD (people with diabetes or hypertension) needs to annually get their urine tested. However only 50% of people with diabetes and 30% of people with hypertension have a regular urine test reported. Over 1 million cases of CKD remain undetected. Diffusing Dip.io to every at risk patient (8.3m) could improve adherence with no additional overhead, reducing CKD cost by up to £1bn.
  • Urgent and Emergency Care (Urinary Tract Infection): Conducting common diagnostic tests at the patient's home supports "improving the ability of patients to self-care for minor illnesses" (UECR).  This includes the need to anticipate recurring conditions such as UTIs. 1-3% of GP visits are UTI related and UTIs accounted for 14% of emergency hospital admissions in MS patients costing the NHS over £43 million. Dip.io offers the opportunity to improve self-management for patients at risk of admission from UTI, reduce the 5m GP attendances for UTI in primary care and create digital pathways for preop assessment within existing clinical guidelines.
 
  • Harnessing technology and innovation: Our solution leverages existing technology to transform care delivery and supports the drive to digital adoption. We easily integrate into other technologies (integrated with PKB and Allscripts) and make sure interoperability is built in. We are replicating this model for our next product to bring innovation to woundcare management.
Initial Review Rating
4.60 (1 ratings)
Benefit to WM population:
Our smartphone-enabled digital urinalysis service aims to improve quality and efficiency of existing pathways, driving better patient outcomes and experience.
 
Main benefits:
 
Maternity safety: women with hypertension or diabetes in pregnancy have a higher risk of developing pre-eclampsia, a leading cause of maternity morbidity. NICE CG62 recommends dipstick urinalysis during each prenatal visit to screen for proteinuria, an indicator of pre-eclampsia. Increasing testing in between regular pre-natal visits could reduce Pre-eclampsia complications. Women with at-risk pregnancies receive 7-10 Dip.io kits. Following a defined frequency, the women conducts the test at home. The clinician automatically receives the results and is alerted if results are abnormal for immediate follow-up care. This model of care is being rolled out across mayor HMOs in Israel and received more than 90% preference in a Johns Hopkins usability study. Dip.io has proven to improve women’s experience and could reduce outpatient appointments amongst high risk pregnant women.
  • Diabetes and CKD screening: NICE clinical guidelines recommend people with diabetes/hypertension need to get their urine tested annually but adherence is low e.g.  only 51% of people with type 1 diabetes tested. Digital testing could improve adherence and reduce costs. Patients with no recorded albumin reading receive our smartphone urinalysis home-test. Results are immediately available to the clinician and those with abnormal results are invited to a follow-up extensive checkup. This model makes it possible to reach people at risk, who have not received appropriate testing, thus increasing adherence to CKD screening.
  • Urinary Tract Infection (UTI): opportunity to improve self-management for patients at risk of admission from UTI (e.g.MS), reduce the 5m GP attendances for UTI in primary care and create digital pathways for preop assessment   through using digital urine testing, within existing clinical guidelines.
Current and planned activity: 
NHS:
  • North East and North Cumbria AHSN with South Tees NHS Trust to test renal clinic at home funded by Northern Counties Kidney Foundation
  • NeuroResponse social enterprise based at UCL on Multiple Sclerosis pathway
  • Modality and Yorkshire and Humber AHSN to test diabetes/CKD screening model
  • Howbeck Healthcare to test rollout diabetes/hypertension/CKD screening model in South Cheshire and Vale Royal
  • Salford NHS Trust rollout for renal patient management
  • Care UK rollout for uncomplicated UTI management
  • Applied to the Test beds, have been invited to the follow-up meeting for at risk pregnancy, UTI and renal models
 
International:
  • Usability study in pregnant women at Johns Hopkins with 92% favourability (soon to be published)
  • US National Kidney Federation and Geisinger Health to improve care for people with hypertension
  • Dutch Kidney Foundation and Dutch Health to test population screening for ACR in at risk population compared to other method
  • Rolling out in two HMOs in Israel for at-risk pregnancy model
Return on Investment (£ Value): 
N/A
Return on Investment (Timescale): 
N/A
Ease of scalability: 
Simple
Regional Scalability:
Our plan is to scale regionally and nationally through a B2B2C business model. We offer several commercial packages that differ in terms of scale, level of integration, agreement timeline and distribution/shipment method.  This allows us to partner with different players within the NHS to provide them full digital capabilities through customised, white label kits, a localised application and access to our algorithm in an end-to-end service proposition. Our vision is to serve as the backbone for smartphone enabled, image based medical diagnostics and enable partners to bring our innovation to their existing user base.
Measures:
Healthy.io and the Dip.io solution work together with healthcare organizations to improve efficiency, value and outcomes by digitizing existing pathways. Measure include:
  • Save outpatient appointment and reduce consultation time to reduce resource pressures.
  • Increase clinical guideline adherence, improving patient safety
  • Improve patient experience (e.g. minimise absence from work and avoid travel expenses)
Adoption target:
Start with a phased roll out to try, test and scale the innovation in a regional NHS organisation. We anticipate that success from this roll out will lead to spreading the implementation of the technology to other specialties within the organisation, other hospitals/GPs within the group and to other providers and partners within the WM area.
Read more
Hide details
0
0
Votes
-99999

Created by

Share and Follow